Upgrade to SI Premium - Free Trial

Piper Sandler Downgrades Esperion Therapeutics (ESPR) to Neutral

May 1, 2026 1:56 PM
Piper Sandler analyst David Amsellem downgraded Esperion Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades